Galindo Jr Jose MD Harrisburg, PA - 17109

Galindo Jr Jose MD is categorized under Internal Medicine Practitioners in Harrisburg, PA and active since 2011.

Galindo Jr Jose MD was established in 2011, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Internal Medicine Practitioners business, which does work in the B2C market, and is classified as a Internal Medicine Practitioners, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Jose Galindo Jr at the company’s single location by writing to 810 Sir Thomas Court, Harrisburg, Pennsylvania PA 17109 or by phoning (717) 236-5023. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Galindo Jr Jose MD
Contact Person: Jose Galindo Jr
Address: 810 Sir Thomas Court, Harrisburg, Pennsylvania 17109
Phone Number: (717) 236-5023
Website Address: piwh.com
Annual Revenue (USD): $500.000 to $999.999
Founded: 2011
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Internal Medicine Practitioners
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

Galindo Jr Jose MD was started in 2011 to provide professional Internal Medicine Practitioners under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.

Feel free to contact Jose Galindo Jr for inquiries that concern Galindo Jr Jose MD by calling the company number (717) 236-5023, as your correspondence is most welcome. Additionally, the physical location of the single location of Galindo Jr Jose MD can be found at the coordinates 40.283282,-76.822253 as well as the street address 810 Sir Thomas Court in Harrisburg, Pennsylvania 17109.

For its online presence, you may visit Galindo Jr Jose MD’s website at piwh.com and engage with its social media outlets through on Twitter and on Facebook.